Apollo Hospitals April-June Profit Jumps 42% on Broad-Based Growth

Apollo Hospitals Enterprise Ltd. posted a 42% year-on-year rise in consolidated net profit to ₹433 crore for the quarter ended June 30, 2025, driven by strong growth in healthcare services, diagnostics, and digital health.

Revenue rose 15% to ₹5,842 crore, while EBITDA grew 26% to ₹852 crore. The hospital division earned ₹2,935 crore in revenue, up 11%, with EBITDA at ₹718 crore and a margin of 24.5%. Network beds stood at 8,030 (excluding AHLL and managed beds), with occupancy at 65% versus 68% a year earlier.

Apollo HealthCo, the digital and pharmacy arm, grew revenue 19% to ₹2,472 crore and swung to a ₹57 crore profit from a ₹13 crore loss. Apollo Health and Lifestyle Ltd. narrowed its loss to ₹8 crore on a 19% revenue rise.

Apollo 24/7, the group’s digital platform, reported a 23% YoY rise in GMV to ₹682 crore. The group added 116 new pharmacy stores, taking the total to 6,742.

The company plans to add over 4,300 beds in the next five years with a ₹7,600 crore investment, including expansions in Bengaluru and Hyderabad. It also launched Apollo Zen, an AI-powered preventive health programme, and OraLife for early oral cancer detection.

The board approved the demerger of its digital health and pharmacy business into Apollo Healthtech Ltd. to enable focused capital allocation.